The final results of a Phase 2b human trial into the efficacy of a new tuberculosis (TB) vaccine have been published, indicating safe long-term protection from the devastating disease in around half of the subjects vaccinated. The research will now move into ...
from Google Alert - health https://ift.tt/31Y2qmU
via IFTTT
0 comments:
Post a Comment